You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Clonal cytopenia of unknown significance (CCUS)

Showing 1 - 25 of 7,170
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clonal Cytopenia of Undetermined Significance Trial in Columbus (procedure, drug, other)

Recruiting
  • Clonal Cytopenia of Undetermined Significance
  • Biospecimen Collection
  • +6 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 12, 2022

Clonal Cytopenia of Undetermined Significance, MDS Trial in Saint Louis (Atorvastatin, Rosuvastatin)

Not yet recruiting
  • Clonal Cytopenia of Undetermined Significance
  • Myelodysplastic Syndromes
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 28, 2022

Clonal Cytopenia of Undetermined Significance, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Los Angeles

Not yet recruiting
  • Clonal Cytopenia of Undetermined Significance
  • +4 more
  • Biospecimen Collection
  • +6 more
  • Los Angeles, California
  • +1 more
Oct 4, 2023

CHIP/CCUS Natural History Protocol

Recruiting
  • Clonal Hematopoiesis of Indeterminate Potential
  • Clonal Cytopenia of Undetermined Significance
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 20, 2022

    Clonal Cytopenia of Undetermined Significance, CCUS Clonal Cytopenia of Undetermined Significance Trial in United States

    Recruiting
    • Clonal Cytopenia of Undetermined Significance
    • CCUS Clonal Cytopenia of Undetermined Significance
    • Rochester, Minnesota
    • +11 more
    Jan 24, 2023

    Clonal Cytopenia of Undetermined Significance Trial in United States (Ivosidenib)

    Recruiting
    • Clonal Cytopenia of Undetermined Significance
    • Rochester, Minnesota
    • +5 more
    Apr 4, 2022

    Follow-up Study of ICUS and CCUS Patients

    Enrolling by invitation
    • Myelodysplastic Syndromes
    • Observation and necessary supportive care
    • Suzhou, Jiangsu, China
      The First Affliated Hospital of Soochow University
    Mar 16, 2022

    Clonal Cytopenia of Undetermined Significance, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, Recurrent

    Recruiting
    • Clonal Cytopenia of Undetermined Significance
    • +6 more
    • Ascorbic Acid
    • +12 more
    • Scottsdale, Arizona
    • +4 more
    May 26, 2022

    Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms

    Not yet recruiting
    • Pyruvate Kinase Deficiency
    • +10 more
    • Blood Draw
    • Boston, Massachusetts
      Massachusetts General Hospital
    May 21, 2021

    Preleukemia, MDS, Cytopenia Trial in Copenhagen (Metformin)

    Recruiting
    • Preleukemia
    • +2 more
    • Copenhagen, Copenhagen N, Denmark
      Rigshospitalet
    Jan 20, 2022

    MDS, Chronic Myelomonocytic Leukemia-1, Cytopenia Trial in Denmark, United States (Vitamin C (ascorbic acid), Placebo)

    Recruiting
    • Myelodysplastic Syndromes
    • +2 more
    • Vitamin C (ascorbic acid)
    • Placebo
    • Los Angeles, California
    • +4 more
    Sep 27, 2021

    Hematologic Malignancy Trial in Copenhagen (HM-PRO)

    Active, not recruiting
    • Hematologic Malignancy
    • HM-PRO
    • Copenhagen, Denmark
      Dept. of Hematology
    Jun 14, 2022

    Paroxysmal Nocturnal Hemoglobinuria in ESUS & ETUS

    Recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
    • +3 more
      • London, Ontario, Canada
        London Health Sciences Centre
      May 10, 2022

      Immune System Diseases, Autoimmune Diseases, Inflammation Trial (observational cohort study)

      Not yet recruiting
      • Immune System Diseases
      • +15 more
      • observational cohort study
      • (no location specified)
      Jul 23, 2023

      MDS, Ferroptosis Trial in Pessac (Biological sampling)

      Not yet recruiting
      • Myelodysplastic Syndromes
      • Ferroptosis
      • Biological sampling
      • Pessac, France
      • +2 more
      Jun 19, 2023

      Chemotherapy-Related Complications

      Recruiting
      • Lymphoma
      • Chemotherapeutic Toxicity
      • Blood test for determination of CHIP
      • Toronto, Ontario, Canada
        Sunnybrook Health Sciences Centre
      Aug 3, 2022

      MDS Trial (Fasting-mimicking diet (FMD) and physiotherapy)

      Not yet recruiting
      • Myelodysplastic Syndromes
      • Fasting-mimicking diet (FMD) and physiotherapy
      • (no location specified)
      Jun 22, 2022

      Quality of Life in Asymptomatic Monoclonal Gammopathies

      Recruiting
      • Monoclonal Gammopathy of Undetermined Significance
      • Smoldering Plasma Cell Myeloma
      • Quality-of-Life Assessment
      • Questionnaire Administration
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 25, 2022

      The National Myelodysplastic Syndromes (MDS) Study

      Recruiting
      • Myelodysplastic Syndromes (MDS)
      • Therapeutic
      • Anaheim, California
      • +280 more
      Apr 8, 2022

      Parathyroid Tumor Clonal Status

      Active, not recruiting
      • Parathyroid Tumor
      • Primary Hyperparathyroidism
        • Birmingham, Alabama
        • +2 more
        Aug 11, 2023

        Myelofibrosis Trial in France (Clonal architecture determination)

        Not yet recruiting
        • Myelofibrosis
        • Clonal architecture determination
        • Angers, France
        • +6 more
        Jan 24, 2023

        Immune Thrombocytopenia, Autoimmune Hemolytic Anemia, Evans Syndrome Trial in France (data collection)

        Recruiting
        • Immune Thrombocytopenia
        • +2 more
        • data collection
        • Amiens, France
        • +8 more
        Jul 7, 2023

        MDS Trial in Hong Kong

        Recruiting
        • Myelodysplastic Syndromes
          • Hong Kong, Hong Kong
            Department of Medicine, the University of Hong Kong, Queen Mary
          Nov 3, 2020

          Early Calcific Aortic Valve Disease in Bicuspid Aortic Valve

          Recruiting
          • Bicuspid Aortic Valve
            • Seoul, Korea, Republic of
              Division of Cardiology, Yonsei University Health System, Yonsei
            Nov 30, 2023

            Moderate Aplastic Anemia, Unilineage Bone Marrow Failure Disorders Trial run by the NHLBI (Eltrombopag)

            Active, not recruiting
            Has Results
            • Moderate Aplastic Anemia
            • Unilineage Bone Marrow Failure Disorders
            • Bethesda, Maryland
              National Institutes of Health Clinical Center, 9000 Rockville Pi
            Dec 2, 2021